Chimera Investment (NYSE:CIM) Stock Rating Lowered by Wall Street Zen

Chimera Investment logo with Finance background
Image from MarketBeat Media, LLC.

Chimera Investment (NYSE:CIM - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a report issued on Saturday, Wall Street Zen reports.

Several other analysts also recently weighed in on CIM. Weiss Ratings downgraded Chimera Investment from a "sell (d+)" rating to a "sell (d)" rating in a research note on Friday, September 18th. Keefe, Bruyette & Woods reduced their price objective on shares of Chimera Investment from $13.00 to $11.50 and set a "market perform" rating for the company in a research note on Monday, November 9th. Finally, Royal Bank Of Canada decreased their target price on shares of Chimera Investment from $13.00 to $7.00 and set a "sector perform" rating for the company in a report on Friday, November 13th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Chimera Investment has an average rating of "Reduce" and an average target price of $9.25.

Check Out Our Latest Analysis on Chimera Investment

Chimera Investment Stock Performance

Shares of CIM stock opened at $6.37 on Friday. The stock has a fifty day moving average of $8.72 and a 200 day moving average of $11.87. Chimera Investment has a 52 week low of $6.04 and a 52 week high of $14.18. The firm has a market capitalization of $532.81 million, a price-to-earnings ratio of -2.08 and a beta of 1.75. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 2.46.

Chimera Investment (NYSE:CIM - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.07). Chimera Investment had a positive return on equity of 10.31% and a negative net margin of 19.11%. The company had revenue of ($118.00) million during the quarter, compared to analysts' expectations of $103.10 million.

Institutional Trading of Chimera Investment

Several institutional investors and hedge funds have recently modified their holdings of the company. Nykredit A S bought a new stake in Chimera Investment during the second quarter valued at about $29,000. Sigma Planning Corp lifted its position in shares of Chimera Investment by 18.9% in the third quarter. Sigma Planning Corp now owns 18,423 shares of the real estate investment trust's stock valued at $176,000 after acquiring an additional 2,929 shares in the last quarter. Kennicott Capital Management LLC lifted its position in shares of Chimera Investment by 9.0% in the third quarter. Kennicott Capital Management LLC now owns 35,616 shares of the real estate investment trust's stock valued at $339,000 after acquiring an additional 2,943 shares in the last quarter. Steward Partners Investment Advisory LLC boosted its stake in shares of Chimera Investment by 13,787.5% in the third quarter. Steward Partners Investment Advisory LLC now owns 3,333 shares of the real estate investment trust's stock worth $32,000 after acquiring an additional 3,309 shares during the period. Finally, Integrated Wealth Concepts LLC bought a new position in shares of Chimera Investment in the second quarter worth about $46,000. 48.44% of the stock is currently owned by institutional investors.

Chimera Investment Company Profile

(Get Free Report)

Chimera Investment Corporation is a real estate investment trust (REIT) focused on residential mortgage-related assets. Its investments include residential mortgage loans and residential mortgage-backed securities, as well as commercial mortgage loans and other real estate-related assets. The company seeks to generate income from these assets and may hold them directly or through securitized investments. Its activities are tied primarily to the U.S. mortgage and housing markets. Founded in 2007, Chimera is headquartered in New York.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Chimera Investment Right Now?

Before you consider Chimera Investment, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chimera Investment wasn't on the list.

While Chimera Investment currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines